CANCER – LYMPHOMA

 

UCSF Researchers Report New Risk Factors For Non-Hodgkin’s Lymphoma (news – 1999)                                           http://www.sciencedaily.com/releases/1999/08/990817065339.htm

 

Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors (full – 2000)                                        http://www.jbc.org/content/275/41/31938.full

 

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease            (full – 2002)                       http://bloodjournal.hematologylibrary.org/cgi/content/full/100/2/627

 

Lymphoma may be slowed by cannabis                       (news – 2002)

http://marijuana-ro.com/medical-usage/lymphoma-may-be-slowed-by-cannabis.html

 

High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma                                                                 (abst – 2003)  http://www.ncbi.nlm.nih.gov/pubmed/12970790

 

The Peripheral Cannabinoid Receptor CB2 and CD40 Are Novel Biological Markers That Predict Outcome in Diffuse Large B-Cell Lymphoma of Elderly Patients.

(abst – 2004)  http://abstracts.hematologylibrary.org/cgi/content/abstract/104/11/3256?maxtoshow=&hits=80&RESULTF   ORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=800&resourcetype=HWCIT

 

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. (abst – 2005)                                      http://www.ncbi.nlm.nih.gov/pubmed/16337199?dopt=Abstract

 

Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma         (full – 2006)                                              http://molpharm.aspetjournals.org/content/70/5/1612.full

 

The expression of the peripheral cannabinoid receptor on cells of the immune system and non-Hodgkin’s lymphomas.                                             (abst – 2007)      http://www.ncbi.nlm.nih.gov/pubmed/17613768

 

Medical Marijuana Use and Research Leukemia & Lymphoma Society Statement (full – 2008)                                        http://www.maps.org/mmj/lnls-res.pdf

 

Cannabinoids for Cancer Treatment: Progress and Promise                      (full – 2008)

http://cancerres.aacrjournals.org/content/68/2/339.long

 

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.                                                                      (full – 2008)  http://onlinelibrary.wiley.com/doi/10.1002/ijc.23584/full

 

Cannabis Agonist Reduces Non-Hodgkin Lymphoma Tumor Growth, says study (news – 2008)                                           http://www.illinoisnorml.org/content/view/957/27/

 

Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.                                                            (full – 2009)  http://mcr.aacrjournals.org/content/7/7/1086.long

 

Medical Marijuana and Lymphoma                      (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/40?ailment=lymphoma

 

WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. (full – 2011)                                        http://www.nature.com/cddis/journal/v2/n11/full/cddis2011106a.html

Share a link for